Company Description
Amicus Therapeutics develops drugs that treat rare genetic diseases known as lysosomal storage disorders. The company's...
Key Amicus Therapeutics Financials
| Company Type | Public - NASDAQ (GM): FOLD Main Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2007 Sales (mil.) | $1.8 |
| 2004 Employees | 11 |
More Amicus Therapeutics Financials (8 pages)
Competition
Competitive Landscape for Biotechnology Sector
Demand for biotechnology products and services is driven primarily by the willingness of insurers to pay for new medical treatments. The profitability of individual companies depends on the...
Read more about Amicus Therapeutics's competition across multiple industries
Top Amicus Therapeutics Competitors
Sponsored Links
The Business DirectoryTrading Toolbox
Amicus Therapeutics Executives sponsored by genius.com
| Title | Name & Bio | Contact |
|---|---|---|
| Chairman | Donald J. Hayden Jr. | Network | E-mail |
| President, CEO and Director | John F. Crowley | Network | E-mail |
| COO | Matthew R. Patterson | Network | E-mail |
More Amicus Therapeutics Executives
| Are You Listed On Hoover's? | ||
|---|---|---|
| Hoover's subscribers also get access to information on people who have self-listed with this company. Subscribers also have the option to add themselves to this company record. |
Tools from our advertising partners:
